The Moderna cancer vaccine offers hope — now we must speed up personalized therapies

TL;DR - A Nature commentary argues that a positive Moderna cancer-vaccine trial offers hope for personalized cancer treatment, while emphasizing that further research and faster clinical translation are needed.

• The trial is described as promising, but no efficacy figures or technical details are provided.
• Personalized cancer vaccines could expand treatment options for people with cancer.
• Additional research is required before effective vaccines can reach routine clinical use.
• The article advocates accelerating the development and delivery of personalized therapies.